• Home
  • Oncology Publications

Oncology Publications

Oncology Publications

  • Incident cancer risk after the start of aspirin use: results from a Dutch population-based cohort study of low dose aspirin users.Abstract

    Observational and intervention studies suggest that low dose aspirin use may prevent cancer. The objective of this study was to investigate the protective effect of long term low dose aspirin use (

    Hollestein LM, van Herk-Sukel MP, Ruiter R, de Vries E, Mathijssen RH, Wiemer EA, Stijnen T, Coebergh JW, Lemmens VE, Herings RM, Stricker BH, Nijsten T. Int J Cancer. 2014 Jul 1; 135 (1): 157-65.
  • Expression of HLA Class I Antigen, Aspirin Use, and Survival After a Diagnosis of Colon Cancer.Abstract

    IMPORTANCE Use of aspirin (which inhibits platelet function) after a colon cancer diagnosis is associated with improved overall survival. Identifying predictive biomarkers of this effect could individualize therapy and decrease toxic effects. OBJECIVE To demonstrate that survival benefit associated with low-dose aspirin use after a diagnosis of colorectal cancer might depend on HLA class I antigen expression

    Reimers MS, Bastiaannet E, Langley RE, van Eijk R, van Vlierberghe RL, Lemmens VE, van Herk-Sukel MP, van Wezel T, Fodde R, Kuppen PJ, Morreau H, van de Velde CJ, Liefers GJ. JAMA Intern Med. 2014 May 1; 174 (5): 732-9.
  • beta-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study.Abstract

    BACKGROUND: Results from preclinical and observational studies suggest that beta-adrenoreceptor inhibition might influence disease progression of melanoma. PATIENTS AND METHODS: Patients 18years with cutaneous melanoma (Breslow thickness >1mm) regitered in the Eindhoven Cancer Registry between January 1, 1998 and December 31, 2010, who were also registered with PHARMO record linkage system (RLS), were eligible

    Livingstone E, Hollestein LM, van Herk-Sukel MP, van dePoll-Franse L, Nijsten T, Schaden dorf D, deVries E. Eur J Cancer. 2013 Dec; 49 (18): 3863-71.
  • Pulmonary embolism, myocardial infarction, and ischemic stroke in lung cancer patients: results from a longitudinal study.Abstract

    PURPOSE: In this cohort study, the rates of pulmonary embolism (PE), myocardial infarction (MI), and ischemic stroke (IS) before and after lung cancer (LC) diagnosis were compared to cancer-free controls. METHODS: Patients with LC during 2000-2007ere selected from PALGA, the Dutch Pathology Registry, and linked to the PHARMO medical record linkage system, including drug use and hospitalizations of 3 million inhabitants in the Netherlands

    van Herk-Sukel MP, Shantakumar S, Penning-van Beest FJ, Kamphuisen PW, Majoor CJ, Overbeek LI, Herings RM. Lung. 2013 Oct; 191 (5): 501-9.
  • Exposure to phototoxic NSAIDs and quinolones is associated with an increased risk of melanoma.Abstract

    PURPOSE: Ultraviolet radiation exposure is the most important exogenous risk factor for cutaneous malignancies. It is possible that phototoxic drugs promote the development of cutaneous melanoma (CM) by intensifying the effect of ultraviolet lightn the skin. We investigated the association between the use of common systemic phototoxic drugs and development of CM

    Siiskonen SJ, Koomen ER, Visser LE, Herings RM, Guchelaar HJ, Stricker BH, Nijsten TE. Eur J Clin Pharmacol. 2013 Jul; 69 (7): 1437-44.
  • Major changes in chemotherapy regimens administered to breast cancer patients during 2000-2008 in the Netherlands.Abstract

    There is little information available on the patterns of chemotherapy regimens administered in daily practice to patients with early stage and metastatic or recurrent breast cancer. To determine the trends in type of chemotherapy regimens used in beast cancer patients, newly diagnosed breast cancer patients in the period 2000-2008 who received chemotherapy were identified from the Eindhoven Cancer Registry (ECR) and linked to the PHARMO RLS, including data on, e

    van Herk-Sukel MP, van dePoll-Franse LV, Creemers GJ, Lemmens VE, van der Linden PD, Herings RM, Coebergh JW, Voogd AC. Breast J. 2013 Jul-Aug; 19 (4): 394-401.
  • Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen.Abstract

    Tamoxifen is a largely inactive pro-drug, requiring metabolism into its most important metabolite endoxifen. Since the cytochrome P450 (CYP) 2D6 enzyme is primarily involved in this metabolism, genetic polymorphisms of this enzyme, but also drug-inuced CYP2D6 inhibition can result in considerably reduced endoxifen formation and as a consequence may affect the efficacy of tamoxifen treatment

    Binkhorst L, Mathijssen RH, van Herk-Sukel MP, Bannink M, Jager A, Wiemer EA, van Gelder T. Breast Cancer Res Treat. 2013 Jun; 139 (3): 923-9.
  • Aspirin use after diagnosis improves survival in older adults with colon cancer: a retrospective cohort study.Abstract

    OBJECTIVES: To assess survival in relation to aspirin use after diagnosis in older adults with colon cancer. DESIGN: Subgroup analysis of a previously published cohort and retrospective study. SETTING: Individuals registered in the Eindhoven CancerRegistry (ECR) between 1998 and 2007, linked to prescriptions of low-dose aspirin (80 mg) registered in a community pharmacy database

    Reimers MS, Bastiaannet E, van Herk-Sukel MP, Lemmens VE, van den Broek CB, van deVelde CJ, deCraen AJ, Liefers GJ. J Am Geriatr Soc. 2012 Dec; 60 (12): 2232-6.
  • Use and costs of oral anticancer agents in the Netherlands in the period 2000-2008.Abstract

    PURPOSE: In recent years, the number of oral anticancer agents has increased substantially. Although these agents have quickly been incorporated in the treatment of a variety of malignancies, data on their incidence, prevalence and costs are lackin. The objective of the present study was to obtain insight into the use and the costs of oral anticancer agents (with Anatomical Therapeutic Chemical classification system (World Health Organisation) code L01) in the Netherlands between 2000 and 2008

    Timmers L, Beckeringh JJ, van Herk-Sukel MP, Boven E, Hugtenburg JG. Pharmacoepidemiol Drug Saf. 2012 Oct; 21 (10): 1036-44.
  • Use of Aspirin postdiagnosis improves survival for colon cancer patients.Abstract

    Background:The preventive role of non-steroid anti-inflammatory drugs (NSAIDs) and aspirin, in particular, on colorectal cancer is well established. More recently, it has been suggested that aspirin may also have a therapeutic role. Aim of the presnt observational population-based study was to assess the therapeutic effect on overall survival of aspirin/NSAIDs as adjuvant treatment used after the diagnosis of colorectal cancer patients

    Bastiaannet E, Sampieri K, Dekkers OM, deCraen AJ, van Herk-Sukel MP, Lemmens V, van den Broek CB, Coebergh JW, Herings RM, van deVelde CJ, Fodde R, Liefers GJ. Br J Cancer. 2012 Apr 24; 106 (9): 1564-70.